NASD PLC
OTC Market
Jawa International Limited logo

Series 1 Commercial Paper - ₦2B Issuance

Jawa International Limited · JAWACP26S1

Status

Active

About Commercial Paper

Jawa International Limited was established in 1993 as an indigenous pharmaceutical manufacturing company committed to the production and distribution of high-quality, affordable medicines. The company operates across various segments of the pharmaceutical industry, specializing in the manufacturing of liquid orals, antibiotics, ointments, and creams. With its headquarters in Lagos, Nigeria. Jawa registered a N2 Billion Series 1 Commercial Paper of its N10 Billion Commercial Paper Issuance Programme which will mature on April 17, 2026.


Commercial Paper Information

Thursday, 16 July 2026 at 17:28

Issuer Description Issued Date Maturity Date Tenor (days) Discount(%) Status
Jawa International Limited Series 1 Commercial Paper - ₦2B Issuance 21 Jul, 2025 17 Apr, 2026 270 days 23.2% Active

Related Company Information

CP Title
Series 1 Commercial Paper - ₦2B Issuance
ISIN
NGJAWACP2611
Sector
Manufacturing
Categorization
Debt Instrument
Issue Size
2,000,000
Discount Rate
23.2%
Face Value
1,000
Tenor
270 days
Issue Date
21 Jul, 2025
Maturity Date
17 Apr, 2026
Instrument Type
Jawa International Limited ₦2,000,000,000 Series 1 Commercial Paper Issuance
Credit Ratings
DataPro Limited: (short Term Rating: A2, Long Term Rating: BBB+)
Issuing and Placing Agent(s) (IPA)
Boston Advisory Limited
Collecting and Paying Agent(s) (CPA)
Keystone Bank Limited
Issuing, Placing, Paying and Collecting Agent(s) (IPCA)
N/A
Status
Active

Interested in listing your Commercial Paper?

NASD admits SEC-approved commercial paper from credible Nigerian corporates for transparent trading and visibility.

Join our newsletter

Stay informed with the latest market updates, insights, and announcements from NASD.